Jon P Stonehouse - Net Worth and Insider Trading

Jon P Stonehouse Net Worth

The estimated net worth of Jon P Stonehouse is at least $4 Million dollars as of 2024-04-27. Jon P Stonehouse is the President & CEO of BioCryst Pharmaceuticals Inc and owns about 1,028,739 shares of BioCryst Pharmaceuticals Inc (BCRX) stock worth over $4 Million. Jon P Stonehouse is also the Director of Bellicum Pharmaceuticals Inc and owns about 1,000 shares of Bellicum Pharmaceuticals Inc (BLCM) stock worth over $75. Details can be seen in Jon P Stonehouse's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Jon P Stonehouse has not made any transactions after 2023-02-01 and currently still holds the listed stock(s).

Transaction Summary of Jon P Stonehouse

To

Jon P Stonehouse Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Jon P Stonehouse owns 2 companies in total, including Bellicum Pharmaceuticals Inc (BLCM) , and BioCryst Pharmaceuticals Inc (BCRX) .

Click here to see the complete history of Jon P Stonehouse’s form 4 insider trades.

Insider Ownership Summary of Jon P Stonehouse

Ticker Comapny Transaction Date Type of Owner
BLCM Bellicum Pharmaceuticals Inc 2018-11-09 director
BCRX BioCryst Pharmaceuticals Inc 2023-02-01 director & CEO

Jon P Stonehouse Latest Holdings Summary

Jon P Stonehouse currently owns a total of 2 stocks. Among these stocks, Jon P Stonehouse owns 1,028,739 shares of BioCryst Pharmaceuticals Inc (BCRX) as of February 1, 2023, with a value of $4 Million and a weighting of 100%. Jon P Stonehouse also owns 1,000 shares of Bellicum Pharmaceuticals Inc (BLCM) as of November 9, 2018, with a value of $75 and a weighting of 0%.

Latest Holdings of Jon P Stonehouse

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
BCRX BioCryst Pharmaceuticals Inc 2023-02-01 1,028,739 4.16 4,279,554
BLCM Bellicum Pharmaceuticals Inc 2018-11-09 1,000 0.07 75

Holding Weightings of Jon P Stonehouse


Jon P Stonehouse Form 4 Trading Tracker

According to the SEC Form 4 filings, Jon P Stonehouse has made a total of 6 transactions in BioCryst Pharmaceuticals Inc (BCRX) over the past 5 years, including 1 buys and 5 sells. The most-recent trade in BioCryst Pharmaceuticals Inc is the sale of 100,000 shares on February 1, 2023, which brought Jon P Stonehouse around $1 Million.

According to the SEC Form 4 filings, Jon P Stonehouse has made a total of 0 transactions in Bellicum Pharmaceuticals Inc (BLCM) over the past 5 years. The most-recent trade in Bellicum Pharmaceuticals Inc is the acquisition of 1,000 shares on November 9, 2018, which cost Jon P Stonehouse around $45,600.

Insider Trading History of Jon P Stonehouse

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Jon P Stonehouse Trading Performance

GuruFocus tracks the stock performance after each of Jon P Stonehouse's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jon P Stonehouse is 1.27%. GuruFocus also compares Jon P Stonehouse's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jon P Stonehouse within 3 months outperforms 6 times out of 12 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Jon P Stonehouse's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Jon P Stonehouse

Average Return

168.51%

Average return per transaction

Outperforming Transactions

75%

9 out of 12 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 8.5 1.27 60.57 168.51 36.28 16.06
Relative Return to S&P 500(%) 9.53 7.41 66.91 164.59 30.39 9.71

Jon P Stonehouse Ownership Network

Ownership Network List of Jon P Stonehouse

No Data

Ownership Network Relation of Jon P Stonehouse


Jon P Stonehouse Owned Company Details

What does Bellicum Pharmaceuticals Inc do?

Who are the key executives at Bellicum Pharmaceuticals Inc?

Jon P Stonehouse is the director of Bellicum Pharmaceuticals Inc. Other key executives at Bellicum Pharmaceuticals Inc include Chief Development Officer Charity Scripture , Principal Accounting Officer Charles S. Grass , and director & President and CEO Richard A. Fair .

Bellicum Pharmaceuticals Inc (BLCM) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Bellicum Pharmaceuticals Inc (BLCM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Bellicum Pharmaceuticals Inc (BLCM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Bellicum Pharmaceuticals Inc (BLCM)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Bellicum Pharmaceuticals Inc Insider Transactions

No Available Data

Jon P Stonehouse Mailing Address

Above is the net worth, insider trading, and ownership report for Jon P Stonehouse. You might contact Jon P Stonehouse via mailing address: 2190 Parkway Lake Dr, Birmingham Al 35244.

Discussions on Jon P Stonehouse

No discussions yet.